Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DVA HEALTHCARE RENAL CARE INC

NPI: 1861467607 · APPLE VALLEY, CA 92307 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/22/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more

$6.93M
Total Medicaid Paid
136,013
Total Claims
24,596
Beneficiaries
21
Codes Billed
2018-01
First Month
2024-10
Last Month

Provider Details

Authorized OfficialWINSTEL, JOHN (CHIEF ACCOUNTING OFFICER)
NPI Enumeration Date02/22/2006

Related Entities

Other providers sharing the same authorized official: WINSTEL, JOHN

ProviderCityStateTotal Paid
TOTAL RENAL CARE INC INGLEWOOD CA $22.54M
TOTAL RENAL CARE INC MIAMI FL $16.77M
DVA HEALTHCARE RENAL CARE INC LOS ANGELES CA $14.01M
DVA HEALTHCARE RENAL CARE INC BURBANK CA $10.72M
DVA HEALTHCARE RENAL CARE INC OAKLAND CA $10.67M
DVA HEALTHCARE RENAL CARE INC WESTMINSTER CA $8.32M
DVA HEALTHCARE RENAL CARE INC GLENDALE CA $5.32M
RENAL TREATMENT CENTERS CALIFORNIA INC SANTA ANA CA $5.08M
DVA HEALTHCARE RENAL CARE INC BERKELEY CA $4.25M
TOTAL RENAL CARE INC PLANTATION FL $4.08M
DVA RENAL HEALTHCARE INC LOS ANGELES CA $4.01M
DVA HEALTHCARE OF MASSACHUSETTS INC SALEM MA $3.57M
DVA RENAL HEALTHCARE INC SIERRA VISTA AZ $3.52M
RENAL TREATMENT CENTERS-SOUTHEAST, LP. PANAMA CITY FL $3.14M
WESTON DIALYSIS CENTER LLC WESTON FL $3.01M
BEVERLY HILLS DIALYSIS PARTNERSHIP BEVERLY HILLS CA $2.90M
RENAL TREATMENT CENTERS CALIFORNIA INC EL MONTE CA $2.82M
TOTAL RENAL CARE INC ANTIOCH CA $2.72M
DVA HEALTHCARE RENAL CARE INC PHILADELPHIA PA $2.30M
DVA HEALTHCARE RENAL CARE INC FT LAUDERDALE FL $2.13M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 23,763 $1.18M
2019 28,024 $1.34M
2020 22,310 $1.06M
2021 18,383 $838K
2022 14,778 $803K
2023 17,913 $835K
2024 10,842 $868K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
90999 Unlisted dialysis procedure, inpatient or outpatient 47,641 4,125 $6.73M
A4657 Syringe, with or without needle, each 3,165 1,975 $156K
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) 36,028 2,801 $15K
0250 5,403 378 $8K
82728 1,963 1,828 $7K
J0887 Injection, epoetin beta, 1 microgram, (for esrd on dialysis) 529 299 $7K
J1756 Injection, iron sucrose, 1 mg 7,711 2,068 $5K
J0604 Cinacalcet, oral, 1 mg, (for esrd on dialysis) 194 98 $1K
90661 12 12 $228.47
J1270 Injection, doxercalciferol, 1 mcg 23,506 2,021 $203.80
90674 158 147 $130.63
83970 1,715 1,542 $106.87
83550 1,707 1,574 $24.02
83540 1,962 1,822 $18.58
85041 1,864 1,744 $8.44
85048 1,857 1,739 $7.14
J2405 Injection, ondansetron hydrochloride, per 1 mg 139 44 $0.00
90662 16 16 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 126 126 $0.00
G0008 Administration of influenza virus vaccine 97 94 $0.00
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 220 143 $0.00